Clinical trial
Efficacy Study of Folinic Acid to Improve Mental Development of Children With…
NCT00294593 · Institut Jerome Lejeune, Other · Completed
Key facts
| NCT number | NCT00294593 |
|---|---|
| Title | Efficacy Study of Folinic Acid to Improve Mental Development of Children With Down Syndrome |
| Official title | One-year Double-blind Placebo-controlled Phase 2-3 Study to Evaluate the Effect of Oral Folinic Acid Treatment (1mg/kg/d) on the Psychomotor Development of Young Down Syndrome Patients |
| Lead sponsor | Institut Jerome Lejeune, Other |
| Collaborators | Fondation Jérôme Lejeune |
| Status | Completed |
| Phase | Phase 2/Phase 3 |
| Study type | Interventional |
| Conditions | Down Syndrome |
| Intervention type | Drug |
| Interventions | folinic acid |
| Enrollment | 120 |
| Start date | Oct 1, 2000 |
| Completion | Dec 1, 2003 |
| First posted | Feb 22, 2006 |
| Last update posted | Dec 17, 2009 |
| Countries | France |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: